What Are the Goals of Lung Cancer Treatment?

https://vimeo.com/636548720 The goals of lung cancer treatment can vary depending on the stage. Expert Dr. Heather Wakelee explains how lung cancer stage is determined and shares insight about the goals…

In-Depth Testing for Lung Cancer Prognosis and Treatment

https://vimeo.com/636592338 How is in-depth lung cancer testing used in determining lung cancer prognosis and treatment? Expert Dr. Heather Wakelee shares insight about biomarker testing, genomic testing, and how test results…

Accessing Personalized Treatment for Lung Cancer

Lung cancer expert Dr. Heather Wakelee defines personalized medicine and explains the factors that are considered when determining a treatment approach. Dr. Heather Wakelee is a thoracic medical oncologist and…

An Overview of Current DLBCL Treatment Approaches

https://vimeo.com/635611720 What do diffuse large B-cell lymphoma (DLBCL) patients need to know about current treatment approaches? Expert Dr. Loretta Nastoupil provides an overview and gives an update about ongoing research…

Should DLBCL Treatment Begin Immediately?

https://vimeo.com/635610427 For a newly diagnosed diffuse large B-cell lymphoma (DLBCL) patient, should treatment begin right away? Expert Dr. Loretta Nastoupil discusses the optimal time to begin treatment and how it…

How Does Biomarker Testing Impact DLBCL Treatment Options?

https://vimeo.com/635610213 Biomarker test results may help guide diffuse large B-cell lymphoma (DLBCL) treatment options. Expert Dr. Loretta Nastoupil explains how biomarkers are currently used in determining an optimal treatment approach…

What Are the Stages of DLBCL?

https://vimeo.com/635609828 Diffuse large B-cell lymphoma (DLBCL) care involves the use of a specific staging system. Expert Dr. Loretta Nastoupil shares insight about the DLBCL staging system and explains what is…

MPN Research and Optimism About Curative Therapies

https://vimeo.com/636610046 Myeloproliferative neoplasm (MPN) researcher Dr. John Mascarenhas discusses why he’s excited about the future of care for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr….

Share On:

Facebook
Twitter
LinkedIn